| Entry |
|
|---|
| Name |
Pranlukast (INN);
Azlaire (TN) |
|---|
| Formula |
C27H23N5O4
|
|---|
| Exact mass |
481.175
|
|---|
| Mol weight |
481.5026
|
|---|
| Structure |
|
|---|
| Class |
Anti-allergic agent
DG01541 Cysteinyl leukotriene receptor antagonist
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
|
|---|
| Remark |
| Product (DG01065): | D02732<JP> |
|
|---|
| Efficacy |
Antiallergic, Antiasthmatic, Anti-inflammatory, Leukotriene receptor antagonist |
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Metabolism |
Enzyme: CYP3A4 [HSA: 1576]
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07228 | Eicosanoid receptor agonists/antagonists |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03D OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03DC Leukotriene receptor antagonists
R03DC02 Pranlukast
D08408 Pranlukast (INN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01541 Cysteinyl leukotriene receptor antagonist
DG01065 Pranlukast
D08408 Pranlukast
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01065 Pranlukast
D08408 Pranlukast
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Cysteinyl leukotriene
CYSLTR1
D08408 Pranlukast (INN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08408
Drug groups [BR:br08330]
Anti-allergic agent
DG01541 Cysteinyl leukotriene receptor antagonist
DG01065 Pranlukast
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG01065 Pranlukast
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 36
1 C8y C 22.3300 -19.3200
2 C8x C 23.5200 -20.0900
3 C8x C 24.7800 -19.3200
4 C8y C 24.7800 -17.9200
5 C8x C 23.5200 -17.2200
6 C8x C 22.3300 -17.9200
7 C5a C 21.1400 -20.0900
8 N1b N 19.8800 -19.3900
9 O5a O 21.1400 -21.4900
10 C8y C 18.6900 -20.0200
11 C8y C 17.5000 -19.3900
12 C8y C 16.3100 -20.0900
13 C8x C 16.3100 -21.4900
14 C8x C 17.5000 -22.1900
15 C8x C 18.6900 -21.4200
16 O2a O 25.9700 -17.2200
17 C1b C 27.2300 -17.9200
18 C1b C 28.4200 -17.2200
19 C1b C 29.6100 -17.9200
20 C1b C 30.8700 -17.2200
21 C8y C 32.0600 -17.9200
22 C8x C 32.0600 -19.3200
23 C8x C 33.3200 -20.0900
24 C8x C 34.5100 -19.3200
25 C8x C 34.5100 -17.9200
26 C8x C 33.3200 -17.2200
27 O2x O 17.5000 -17.9900
28 C8y C 16.3100 -17.2200
29 C8x C 15.1200 -17.9900
30 C8y C 15.1200 -19.3900
31 C8y C 16.3100 -15.8200
32 N4x N 17.4300 -15.0500
33 N5x N 17.0100 -13.7200
34 N5x N 15.6100 -13.7200
35 N5x N 15.1900 -15.0500
36 O5x O 13.8600 -20.0900
BOND 40
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 7 8 1
9 7 9 2
10 8 10 1
11 10 11 2
12 11 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 10 15 1
17 4 16 1
18 16 17 1
19 17 18 1
20 18 19 1
21 19 20 1
22 20 21 1
23 21 22 2
24 22 23 1
25 23 24 2
26 24 25 1
27 25 26 2
28 21 26 1
29 11 27 1
30 27 28 1
31 28 29 2
32 29 30 1
33 12 30 1
34 28 31 1
35 31 32 1
36 32 33 1
37 33 34 2
38 34 35 1
39 31 35 2
40 30 36 2
|
|---|
